A detailed history of Wedmont Private Capital transactions in Abbott Laboratories stock. As of the latest transaction made, Wedmont Private Capital holds 13,639 shares of ABT stock, worth $1.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
13,639
Previous 12,793 6.61%
Holding current value
$1.6 Million
Previous $1.33 Million 16.93%
% of portfolio
0.09%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$100.07 - $118.13 $84,659 - $99,937
846 Added 6.61%
13,639 $1.55 Million
Q2 2024

Jul 15, 2024

SELL
$100.73 - $112.44 $43,414 - $48,461
-431 Reduced 3.26%
12,793 $1.33 Million
Q1 2024

Apr 10, 2024

BUY
$109.52 - $120.96 $123,976 - $136,926
1,132 Added 9.36%
13,224 $1.5 Million
Q4 2023

Jan 09, 2024

BUY
$90.19 - $110.4 $221,687 - $271,363
2,458 Added 25.51%
12,092 $1.33 Million
Q3 2023

Oct 10, 2023

BUY
$95.53 - $114.62 $97,440 - $116,912
1,020 Added 11.84%
9,634 $933,000
Q2 2023

Jul 17, 2023

BUY
$100.78 - $112.29 $215,165 - $239,739
2,135 Added 32.95%
8,614 $939,000
Q1 2023

Apr 11, 2023

SELL
$96.86 - $114.01 $218,322 - $256,978
-2,254 Reduced 25.81%
6,479 $656,000
Q4 2022

Jan 09, 2023

BUY
$95.06 - $111.52 $47,339 - $55,536
498 Added 6.05%
8,733 $0
Q3 2022

Oct 03, 2022

BUY
$96.76 - $112.03 $55,637 - $64,417
575 Added 7.51%
8,235 $797,000
Q2 2022

Jul 11, 2022

BUY
$102.07 - $123.37 $36,030 - $43,549
353 Added 4.83%
7,660 $832,000
Q1 2022

Apr 05, 2022

SELL
$114.02 - $139.04 $41,161 - $50,193
-361 Reduced 4.71%
7,307 $869,000
Q4 2021

Jan 14, 2022

BUY
$115.53 - $141.46 $885,884 - $1.08 Million
7,668 New
7,668 $994,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wedmont Private Capital Portfolio

Follow Wedmont Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Wedmont Private Capital with notifications on news.